Director Childs Buys 29,000 BHVN Shares

January 1, 2025

Today’s most notable transaction comes from John W. Childs, director of Biohaven Pharmaceutical Holding Company $BHVN.

Childs bought 29,000 shares, equivalent to $1,042,393 in its latest Form 4 filing.

Here’s The Hot Corner, with data from December 31, 2024:

Happy New Year, everyone!

Article Sales Message

Know the trading behavior of …

Our experienced team of analysts work through the Form 4, 13D and 13G filings to provide you a list of the best trade ideas.

You need to have a subscription to access this content in full.

Filed Under: